Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	44.00	44.20	30.70
Graham Fair Price	-8.41	9.80	10.70
PEG	-26.44	-1.72	-1.36
Price/Book	3.10	1.83	1.78
Price/Cash Flow	348.37	131.19	29.26
Prices/Earnings	25.12	26.83	21.45
Price/Sales	19.51	6.41	5.36
Price/FCF	348.37	131.19	29.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.88	0.33	0.35
Operating Margin	-29.05	0.11	0.15
ROA	-13.87	< 0.005	0.01
ROE	0.02	0.02	-17.60
ROIC	0.02	0.01	-23.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.06	46.35
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.30	-0.39	29.23
EPS QOQ	-0.16	-0.16	1.04
FCF QOQ	2.66	-0.77	-70.99
Revenue QOQ	0.13	-0.14	9.00
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	125.14	154.15	23.18
Days Sales Outstanding (DSO)	68.11	70.30	3.22
Inventory Turnover	0.72	0.58	-18.82
Debt/Capitalization	0.33	0.35	5.09
Quick Ratio	1.08	0.93	-13.60
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.66	15.80	0.90
Cash	1.22	1.09	-10.62
Capex	-0.44	-0.35	20.67
Free Cash Flow	0.95	0.22	-76.80
Revenue	5.19	4.52	-12.96
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.07	2.05	-1.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.44	8.96	39.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating